Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study.

Background:Reduction in absolute lymphocyte count (ALC) is expected with fingolimod treatment.Objective:To evaluate the effect of fingolimod 0.5 mg versus intramuscular interferon β-1a (30 μg) on A...